Meglumine antimoniate warnings and precautions
Jump to navigation
Jump to search
| Meglumine Antimoniate |
|---|
| GLUCANTIM® WHO Prescribing Information |
| Description |
| Indications and Usage |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Dosage and Administration |
| How Supplied |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Warnings and Precautions
A protein-rich diet should be provided throughout treatment and, where possible, iron depletion and other specific deficiencies should be corrected beforehand.
When possible, both the electrocardiogram and renal and hepatic function should be monitored throughout treatment. Dosage must be reduced should abnormalities occur.
Use in pregnancy
Safe use in pregnancy has not been established. However, because it is potentially fatal, visceral leishmaniasis should always be treated without delay.[1]
References
Adapted from the FDA Package Insert.